Docetero RTU Injection (Docetaxel Injection IP 120 mg)

Docetero RTU Injection is a branded oncology injectable containing docetaxel, a well-established taxane-class antineoplastic agent. Manufactured using Ready-to-Use (RTU) technology, this formulation is designed to streamline preparation processes in regulated oncology environments. Docetero RTU Injection with Docetaxel Injection IP 120 mg is supplied by AmeriDrugs for export-oriented pharmaceutical distribution to licensed importers, distributors, hospitals, pharmacies, and oncology-focused procurement channels.

Active Ingredient (API + Strength)

• Active Pharmaceutical Ingredient: Docetaxel IP

• Strength: 120 mg per 6 ml

• Dosage Form: Sterile injectable solution

Therapeutic Use (Informational, Non-Advisory)
Docetaxel is a semi-synthetic taxane antineoplastic agent utilized within approved oncology treatment frameworks for a range of solid tumors. Docetero RTU Injection is incorporated into institutional chemotherapy protocols in accordance with regulatory approvals and established clinical guidelines. This information is provided solely for product identification and regulatory transparency and does not constitute medical advice or treatment guidance.

Dosage Form & Route of Administration

• Dosage Form: Ready-to-use injectable solution

• Route of Administration: Intravenous infusion after dilution

• Prescription Status: Prescription-only medicine

• Intended for professional handling within regulated pharmaceutical and oncology settings

Quality & Manufacturing Standards
Docetero RTU Injection is manufactured in compliance with current Good Manufacturing Practices (GMP) and applicable pharmacopeial standards. RTU formulation technology supports product stability, sterility assurance, and batch-to-batch consistency. Each batch undergoes comprehensive quality control testing to meet international export and regulatory requirements.

Packaging Information (Export-Oriented)

• Primary Packaging: Glass vial containing 6 ml sterile solution

• Secondary Packaging: Printed carton with regulatory-compliant labeling

• Packaging optimized for oncology supply chains and international logistics

• Export documentation and destination-market labeling support available

Target Buyers

• Licensed pharmaceutical importers and distributors

• Oncology hospitals and cancer treatment centers

• Retail and wholesale pharmacies operating under prescription regulations

• Government and private institutional procurement agencies

• International distributors specializing in oncology injectables

Regulatory & Compliance Note
Docetero RTU Injection is a prescription-only oncology medicine intended for regulated pharmaceutical distribution. Not for direct consumer self-use. Product supply is subject to import authorization, local drug regulatory approvals, and institutional procurement policies in the destination country. AmeriDrugs adheres to international export compliance standards and supports regulatory documentation for global markets.